Approved for Nimodipine is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition (i.e., Hunt and Hess Grades I-V).. Nimodipine is a calcium channel blocker. The contractile processes of smooth muscle…
Loading full data from Know Your Drugs Institute…